Nitrous oxide

Description

Nitrous Oxide USP (UN1070) is a non-flammable gas classified as an oxidizer (5.1). It has a Chemical Abstracts Service (CAS) registry number of 10024-97-2.

Uses and Indications

This drug is indicated for use in medical settings where Nitrous Oxide is deemed appropriate for analgesia and sedation. Administration of Nitrous Oxide may be hazardous or contraindicated; therefore, it is to be used only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrous Oxide. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the requirement for administration by qualified personnel, ensuring that all safety protocols and guidelines are strictly followed. There are no specific teratogenic or nonteratogenic effects associated with this drug noted in the available data.

Dosage and Administration

Administration of Nitrous Oxide is to be conducted exclusively by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner must be well-versed in the indications, effects, dosages, methods, and frequency and duration of administration.

Nitrous Oxide is administered via the respiratory route through inhalation. It is essential that practitioners adhere to established safety protocols and guidelines when administering this agent, as its use may pose hazards or be contraindicated in certain situations. Proper training and familiarity with the substance are critical to ensure patient safety and effective outcomes.

Contraindications

Administration of Nitrous Oxide is contraindicated in situations where it may pose a hazard. It should only be used by or under the supervision of a licensed practitioner experienced in its administration, who is knowledgeable about its indications, effects, dosages, methods, frequency, duration, hazards, contraindications, side effects, and necessary precautions.

Specific contraindications include:

• Avoid breathing the gas directly.

• Prevent contact of the liquid with eyes, skin, and clothing.

• In cases of frostbite, do not rub the affected area.

• Use only equipment that has been cleaned for oxygen and is rated for cylinder pressure.

• Do not remove the product label.

Warnings and Precautions

Administration of Nitrous Oxide may pose significant risks and is contraindicated in certain situations. It is imperative that this agent be used solely by or under the supervision of a licensed practitioner who possesses expertise in the use and administration of Nitrous Oxide. This practitioner must be well-versed in the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Nitrous Oxide is classified as a high-pressure oxidizing liquid and gas, which vigorously accelerates combustion. It can lead to rapid suffocation and may induce anesthetic effects. Additionally, exposure to Nitrous Oxide can result in frostbite.

General precautions must be observed to ensure safe handling and administration. It is essential to avoid inhalation of the gas and to ensure adequate ventilation during use. All equipment must be cleaned for oxygen use and rated for cylinder pressure, with strict avoidance of oil and grease. Care should be taken to prevent liquid from contacting the eyes, skin, or clothing. Cylinder temperatures must not exceed 52°C (125°F), and valves should be opened slowly. After each use and when the cylinder is empty, the valve should be closed. A backflow preventive device should be utilized in the piping, and all handling should comply with the Material Safety Data Sheet (MSDS).

In the event of an emergency, immediate first aid measures should be taken. If Nitrous Oxide is inhaled, the individual should be removed to fresh air and kept comfortable for breathing. It is crucial to contact a poison center or a physician if the individual feels unwell. For skin exposure resulting in frostbite, thaw the affected areas with lukewarm water without rubbing, and seek immediate medical advice or attention.

In cases of frostbite, it is vital to obtain medical treatment without delay.

Side Effects

Administration of Nitrous Oxide may pose significant risks and should only be conducted by or under the supervision of a licensed practitioner experienced in its use. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Serious adverse reactions associated with Nitrous Oxide include the potential for anesthetic effects, which can lead to rapid suffocation. Additionally, the substance is classified as a high-pressure oxidizing liquid and gas, which vigorously accelerates combustion and poses a risk of frostbite upon contact with skin. In the event of inhalation, it is critical to remove the affected individual to fresh air. If breathing difficulties arise, oxygen should be administered, and a physician should be contacted immediately. For skin exposure, it is advised to thaw any frostbitten areas with lukewarm water without rubbing the affected region, and to seek immediate medical advice or attention.

Furthermore, it is important to note that Nitrous Oxide contains a chemical recognized by the state of California as a potential cause of birth defects or other reproductive harm. This warning underscores the necessity for careful consideration and adherence to safety protocols during administration.

Drug Interactions

There are currently no specific drug interactions or drug and laboratory test interactions identified for the medication. As such, no dosage adjustments or monitoring recommendations are necessary at this time. Healthcare professionals should continue to assess the patient's overall medication regimen and clinical status to ensure optimal therapeutic outcomes.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrous Oxide, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Administration of Nitrous Oxide may pose hazards or be contraindicated for pediatric patients. It is essential that Nitrous Oxide is used only by or under the supervision of a licensed practitioner who has experience in its use and administration, particularly in the pediatric population. Specific dosing differences, safety concerns, or special precautions for children are not provided in the available information.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

This product contains a chemical known to the state of California to cause birth defects or other reproductive harm. Pregnant patients should be informed of the potential risks associated with exposure to this product. Healthcare professionals are advised to weigh the benefits against the risks when considering the use of this product in women who are pregnant or may become pregnant. It is recommended that women of childbearing potential use effective contraception during treatment to minimize the risk of fetal exposure.

Lactation

Lactating mothers should be aware that this product contains a chemical known to the state of California to cause birth defects or other reproductive harm. Due to the potential risks associated with this chemical, caution is advised when considering the use of this product during lactation.

There is currently no available data on the excretion of this product in human breast milk or its effects on breastfed infants. Healthcare professionals should weigh the potential benefits against the risks when advising lactating mothers regarding the use of this product.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

Overdosage of Nitrous Oxide can result in significant adverse effects that may pose serious health risks. Healthcare professionals should be aware of the potential consequences and symptoms associated with excessive exposure to this agent.

Potential Symptoms Symptoms indicative of Nitrous Oxide overdosage may include dizziness, nausea, vomiting, and loss of consciousness. These manifestations can vary in severity and may escalate rapidly, necessitating prompt intervention.

Recommended Actions In the event of suspected overdosage, it is imperative to seek immediate medical attention. Timely evaluation and management are crucial to mitigate the risks associated with overdosage.

Management Procedures The treatment of Nitrous Oxide overdosage should be primarily symptomatic and supportive. Healthcare providers should focus on stabilizing the patient and addressing any specific symptoms that arise during the clinical assessment. Continuous monitoring and supportive care are essential to ensure patient safety and recovery.

Nonclinical Toxicology

This product contains a chemical known to the state of California to cause birth defects or other reproductive harm. No specific non-teratogenic effects have been identified in the available data. Additionally, there are no detailed findings regarding nonclinical toxicology or animal pharmacology and toxicology provided in the current information.

Postmarketing Experience

Administration of Nitrous Oxide may pose hazards or contraindications and is recommended solely for use by or under the supervision of a licensed practitioner experienced in its administration. Such practitioners should be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Additionally, it is important to note that this product contains a chemical recognized by the state of California as a potential cause of birth defects or other reproductive harm.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrous Oxide may pose hazards or be contraindicated. It is essential that this substance is used only by or under the supervision of a licensed practitioner who is experienced in its use and administration. Patients should be informed that the practitioner must be familiar with the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Providers must communicate the following warnings to patients: Nitrous Oxide is a high-pressure oxidizing liquid and gas that vigorously accelerates combustion, can cause rapid suffocation, and may induce anesthetic effects. Additionally, patients should be made aware that exposure to Nitrous Oxide can result in frostbite.

Patients should be instructed to avoid breathing the gas and to ensure adequate ventilation during its use. They should be cautioned to keep oil and grease away from the area of use and to utilize only equipment that has been cleaned for oxygen and is rated for cylinder pressure. It is critical to avoid contact with liquid Nitrous Oxide in the eyes, on the skin, or on clothing. Providers should emphasize that cylinder temperatures must not exceed 52°C (125°F), and that the valve should be opened slowly and closed after each use and when empty. The use of a backflow preventive device in the piping is also recommended, and patients should follow the guidelines outlined in the Material Safety Data Sheet (MSDS).

In the event of inhalation, patients should be instructed to seek fresh air immediately. If breathing difficulties arise, they should receive oxygen and contact a physician. In cases of frostbite, patients must obtain medical treatment without delay. If frostbite occurs, they should thaw the affected areas with lukewarm water without rubbing and seek immediate medical advice or attention.

Lastly, healthcare providers should inform patients that this product contains a chemical known to the state of California to cause birth defects or other reproductive harm.

Storage and Handling

The product is supplied in a manner that ensures safe handling and effective use. It is essential to store and utilize the product in an area with adequate ventilation to prevent the accumulation of harmful vapors. Care should be taken to keep oil and grease away from the product to maintain its integrity and safety.

When handling the product, only equipment that has been thoroughly cleaned for oxygen use and is rated for cylinder pressure should be employed. It is critical to monitor cylinder temperatures, ensuring they do not exceed 52°C (125°F).

Users should open the valve slowly to prevent sudden pressure changes and must close the valve after each use and when the cylinder is empty. To enhance safety, a backflow preventive device should be installed in the piping system. All handling and usage should be conducted in accordance with the Material Safety Data Sheet (MSDS) to ensure compliance with safety protocols.

Additional Clinical Information

The route of administration for the product is via respiratory inhalation. Clinicians should be aware that the administration of Nitrous Oxide may pose hazards or be contraindicated. It is intended for use only by or under the supervision of a licensed practitioner who is experienced in its use and familiar with its indications, effects, dosages, methods, frequency, duration, hazards, contraindications, side effects, and necessary precautions.

In the event of inhalation, patients should be moved to fresh air, and if breathing difficulties arise, oxygen should be administered, followed by contacting a physician. For skin exposure, affected areas should be thawed with lukewarm water without rubbing, and immediate medical advice or attention should be sought.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrous Oxide as submitted by Corrigan Propane LLC dba Blue Water Industrial Products. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)